| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,668 |
-
|
-
| 3,976 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 3,668 |
-
|
-
| 3,976 | | | Operating Expenses | | Research Development | 2,327 | 1,659 | 1,953 | 3,440 | | Selling General and Administrative | 912 | 1,011 | 1,160 | 2,490 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 430 | (2,670) | (3,113) | (1,954) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 19 | 50 | (86) | | Earnings Before Interest And Taxes | 430 | (2,651) | (3,063) | (2,040) | | Interest Expense | 345 | 400 | 454 | 507 | | Income Before Tax | 85 | (3,051) | (3,517) | (2,548) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 85 | (3,051) | (3,517) | (2,548) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 85 | (3,051) | (3,517) | (2,548) | | Preferred Stock And Other Adjustments | (251) | (251) | (251) | (251) | | | Net Income Applicable To Common Shares | ($166) | ($3,302) | ($3,768) | ($2,799) |
|
0.51% Nasdaq 
0.045 (5.00%) 
Income Statement
